Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Travere Therapeutics
ISIN US89422G1076
|WKN A2QHYP
Market cap (in EUR)
2 205 M
Country
États-Unis
Sector
Santé
Dividend yield
0,00%
Overview
Description
Travere Therapeutics, Inc. est une société biopharmaceutique. Elle se consacre à l'identification, au développement, à la commercialisation et à la distribution de thérapies destinées aux personnes atteintes de maladies rares. Les produits de la société comprennent le Chenodal, le Cholbam et le Thiola. La société a été fondée par Martin Shkreli le 7 février 2008 et son siège social se trouve à San Diego, en Californie.
Santé Produits biopharmaceutiques Produits biopharmaceutiques systémiques États-Unis
Financials
Key metrics
| Market capitalisation, EUR | 2 205 M |
| EPS, EUR | -0,53 |
| P/B ratio | 21,8 |
| P/E ratio | - |
| Dividend yield | 0,00% |
Income statement (2025)
| Revenue, EUR | 435 M |
| Net income, EUR | -45 M |
| Profit margin | -10,24% |
What ETF is Travere Therapeutics in?
There are 2 ETFs which contain Travere Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Travere Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0,22% | Equity United States Health Care Biotech | 47 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0,04% | Equity United States Small Cap | 187 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.